Cytotoxic profile of natural and some modified bufadienolides from toad Rhinella schneideri parotoid gland secretion

Toxicon

Volumn 56, Issue 3, 2010, Pages 339-348

  Cunha Filho, Geraldino A ^a   Resck, Inês S ^a   Cavalcanti, Bruno C ^b   Pessoa, Cláudia Ó ^b   Moraes, Manoel O ^b   Ferreira, José R O ^b   Rodrigues, Felipe A R ^b   dos Santos, Maria L ^a  

^a UNIVERSITY OF BRASILIA   (Brazil)

^b FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

20S,21R Epoxymarinobufagin; Bufadienolides; Cytotoxic profile; Rhinella schneideri

Indexed keywords

20,21 EPOXYMARINOBUFAGIN; 3BETA ACETOXY 20,21 EPOXYMARINOBUFAGIN; 3BETA ACETOXY BUFALIN; 3BETA ACETOXY MARINOBUFAGIN; 3BETA ACETOXY TELOCINOBUFAGIN; BUFADIENOLIDE DERIVATIVE; BUFALIN; HELLEBRIGENIN; MARINOBUFAGENIN; SITOSTEROL; TELOCINOBUFAGIN; UNCLASSIFIED DRUG;

ACETYLATION; ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CELL STRAIN HL 60; CHEMICAL MODIFICATION; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG ISOLATION; DRUG STRUCTURE; ERYTHROCYTE; HEMOLYSIS; HUMAN; HUMAN CELL; LYMPHOCYTE; NONHUMAN; PAROTID GLAND; PRIORITY JOURNAL; RHINELLA SCHNEIDERI; SALIVA ANALYSIS; SALIVATION; STRUCTURE ACTIVITY RELATION; TOAD; TOXIN ANALYSIS;

BUFANOLIDES; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; PAROTID GLAND; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

ANURA;

EID: 77954144034     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2010.03.021     Document Type: Article

References (75)

1. Ardelt W., Shogen K., Darzynkiewicz Z. Onconase and amphinase, the antitumor ribonucleases from Rana pipiens oocytes. Cur. Pharm. Biotechnol. 2008, 9(3):215-225.
2. Awad A.B., Chinnam M., Fink C.S., Bradford P.G. β-Sitosterol activates Fas signaling in human breast cancer cells. Phytomedicine 2007, 14(11):747-754.
3. Bagrov A.Y., Bagrov Y.Y., Fedorova O.V., Kashkin V.A., Patkina N.A., Zvartau E.E. Endogenous digitalis-like ligands of the sodium pump: possible involvement in mood control and ethanol addiction. Eur. Neuropsychopharmacol. 2002, 12(1):1-12.
4. +-ATPase inhibitor in patients after acute myocardial infarction. Hypertension 1998, 31(5):1097-1103.
5. Berlinck R.G.S., Ogawa C.A., Almeida A.M.P., Andrade M.A.S., Malpezzi E.L.A., Costa L.V., Hajdu E.M., Freitas J.C. Chemical and pharmacological characterization of halitoxin from Amphimedon viridis (PORIFERA) from the southeastern Brazilian coast. Comp. Biochem. Physiol. Part C Toxicol. Pharmacol. 1996, 115:155-163.
6. Crouch N.R., Toit K., Mulholland D.A., Drewes S.E. Bufadienolides from bulbs of Urginea lydenburgensis (Hyacinthaceae: Urgineoideae). Phytochemistry 2006, 67(19):2140-2145.
7. Crow J.P. Dichlorodihydrofluorescein and dihydrorhodamine 123 are sensitive indicators of peroxynitrite in vitro: implications for intracellular measurement of reactive nitrogen and oxygen species. Nitric Oxide 1997, 1:147-157.
8. +K pump current in cardiac myocytes. Eur. J. Pharmacol. 1993, 239(1-3):223-226.
9. Cunha-filho G.A., Schwartz C.A., Resck I.S., Murta M.M., Lemos S.S., Castro M.S., Kyaw C., Pires O.P., Leite J.R.S., Bloch C., Schwartz E.F. Antimicrobial activity of the bufadienolides marinobufagin and telocinobufagin isolated as major components from skin secretion of the Bufo rubescens. Toxicon 2005, 45(6):777-782.
10. Daly J.W., Noimai N., Kongkathip B., Kongkathip N., Wilham J.M., Garraffo H.M., Kaneko T., Spande T.F., Nimit Y., Nabhitabhata J., Chan-Ard T. Biologically active substances from amphibians: preliminary studies on anurans from twenty-one genera of Thailand. Toxicon 2004, 44(8):805-815.
11. Daniel D., Süsal C., Kopp B., Opelz G., Terness P. Apoptosis-mediated selective killing of malignant cells by cardiac steroids: maintenance of cytotoxicity and loss of cardiac activity of chemically modified derivatives. Int. Immunopharmacol. 2003, 3:1791-1801.
12. Della Greca M., Monaco P., Previtera L. Stigmasterol from Thipha latoflia. J. Nat. Prod. 1990, 53(6):1430-1435.
13. Dmitrieva R.I., Bagrov A.Y., Lalli E., Sassone-Corsi P., Stocco D.M., Doris P.A. Mammalian bufadienolides is synthesized from cholesterol in the adrenal cortex by a pathway that is independent of cholesterol side-chain cleavage. Hypertension 2000, 36:442-448.
14. Eisner T., Wiemer D.F., Haynes L.W., Meinwald J. Defense mechanisms of arthropods. 59. Lucibufagins: defensive steroids from the fireflies Photinus ignitus and P. marginellus (Coleoptera: Lampyridae). Proc. Natl. Acad. Sci. U.S.A. 1978, 75(2):905-908.
15. Enomoto A., Rho M.-C., Komiyama K., Hayashi M. Inhibitory effects of bufadienolides on interleukin-6 in MH-60 cells. J. Nat. Prod. 2004, 67(12):2070-2072.
16. Fedorova O.V., Talan M.I., Agalakova N.I., Lakatta E.G., Bagrov A.Y. Endogenous ligand of alpha(1) sodium pump, marinobufagenin, is a novel mediator of sodium chloride - dependent hypertension. Circulation 2002, 105:1122-1127.
17. Hempel S.L., Buettner G.R., O'Malley Y.Q., Wessels D.A., Flaherty D.M. Dihydrofluorescein diacetate is superior for detecting intracellular oxidants: comparison with 2',7'-dichlorodihydrofluorescein diacetate, 5 (and 6)-carboxy-2',7'- dichlorodihydrofluorescein diacetate, and dihydrorhodamine 123. Free Radic. Biol. Med. 1999, 27:146-159.
18. Heyes R.A., Piggott A.M., Dalle K., Capon R.J. Microbial biotransformation as a source of chemical diversity in cane toad steroid toxins. Bioorg. Med. Chem. Lett. 2009, 19(6):1790-1792.
19. Hilton P.J., White R.W., Lord G.A., Garner G.V., Gordon D.B., Hilton M.J., Forni L.G., McKinnon W., Ismail F.M.D., Keenan M., Jones K., Morden W.E. An inhibitor of the sodium pump obtained from human placenta. Lancet 1996, 348(9023):303-305.
20. Hutchinson D.A., Mori A., Savitzky A.H., Burghardt G.M., Wu X., Meinwald J., Schroeder F.C. Dietary sequestration of defensive steroids in nuchal glands of the Asian snake Rhabdophis tigrinus. Proc. Natl. Acad. Sci U.S.A. 2007, 104(7):2265-2270.
21. Imai S., Murase H., Katori M., Okada M., Shigei T. A study on the structure-activity relationship of the cardiotonic steroids. Jpn. J. Pharmacol. 1965, 15:62-71.
22. Kamano Y., Pettit G.R., Tozawa M., Komeich Y., Inoue M. Bufadienolides. 30. Synthesis of the Ch'an su component 15β-Hydroxybufalin. J. Org. Chem. 1975, 40(14):2136-2138.
23. Kamano Y., Satoh N., Nakayoshi H., Pettit G.R., Smith C.R. Rhinovirus inhibition by bufadienolides. Chem. Pharm. Bull. 1988, 36(1):326-332.
24. Kamano Y., Yamamoto H., Hatayama K., Tanaka Y., Shinohara M., Komatsu M. Bufadienolides I. Isolation and structure of a new bufadienolide, resibufagin, and the isolation of marinobufagin. Tetrahedron Lett. 1968, 9(54):5669-5672.
25. Kamano Y., Nogawa T., Yamashita A., Hayashi M., Inoue M., Drasar P., Pettit G.R. Isolation and structure of a 20,21-epoxybufenolide series from " Ch'an su" J. Nat. Prod. 2002, 65(7):1001-1005.
26. Kamano Y., Yamashita A., Nogawa T., Morita H.T.K., Itokawa H., Segawa T., Yukita A., Saito K., Katsuyama M., Pettit G.R. QSAR evaluation of the Ch'an Su and related Bufadienolides against the Colchicine-resistant primary liver carcinoma cell line PLC/PRF/51. J. Med. Chem. 2002, 45:5440-5447.
27. Kawasaki H., Isaacson T., Iwamuro S., Conlon J.M. A protein with antimicrobial activity in the skin of Schlegel's green tree frog Rhacophorus schlegelii (Rhacophoridae) identified as histone H2B. Biochem. Biophys. Res. Commun. 2003, 312(4):1082-1086.
28. +-ATPase in human breast cancer cells. Mol. Pharmacol. 2005, 67(3):929-936.
29. Komiyama Y., Dong X.H., Nishimura N., Masaki H., Yoshica M., Masuda M., Takahashi H. A novel endogenous digitalis, telocinobufagin, exhibits elevated plasma levels in patients with terminal renal failure. Clin. Biochem. 2005, 38(1):36-45.
30. Kuo P.-C., Kuo T.-H., Su C.-R., Liou M.-J., Wu T.-S. Cytotoxic principles and α-pyrone ring-opening derivatives of bufadienolides from Kalanchoe hybrida. Tetrahedron 2008, 64(15):3392-3396.
31. Kupchan S.M., Moniot J.L., Sigel C.W., Hemingway R.J. Tumor Inhibitors. LXV. Bersenogenin, Berscillogenin, and 3-Epiberscillogenin, three new cytotoxic bufadienolides from Bersama abyssinica. J. Org. Chem. 1971, 36(18):2611-2616.
32. LeBel C.P., Ischiopoulos H., Bondy S.C. Evaluation of the probe 2, 7- dichlorofluorescin as indicator of reactive oxygen species formation and oxidative stress. Chem. Res. Toxicol. 1992, 5:227-231.
33. Lee D.Y., Yasuda M., Yamamoto T., Yoshida T., Kuroiwa Y. Bufalin inhibits endothelial cell proliferation and angiogenesis in vitro. Life Sci. 1997, 60(2):127-134.
34. López-Lázaro M., Pastor N., Azrak S.S., Ayuso M.J., Austin C.A., Cortes F. Digitoxin inhibits the growth of cancer cell lines at concentrations commonly found in cardiac patients. J. Nat. Prod. 2005, 68(11):1642-1645.
35. Lu X., Ma Y., Wu J., Lai R. Two serine protease inhibitors from the skin secretions of the toad, Bombina microdeladigitora. Comp. Biochem. Physiol. Part B Biochem. Mol. Bio. 2008, 149(4):608-612.
36. Ma X.-C., Xin X.-L., Liu K.-X., Han J., Guo D.-A. Microbial transformation of Cinobufagin by Syncephalastrum racemosum. J. Nat. Prod. 2008, 71(7):1268-1270.
37. Matsukawa M., Mukai T., Akizawa T., Miyatake S., Yoshioka M., Morris J.F., Butler V.P. Isolation and characterization of novel endogenous digitalis-like factors in the ovary of the Giant Toad, Bufo marinus. J. Nat. Prod. 1998, 61(12):1476-1481.
38. McFoy C., Danosus D., Sandit R., Jones T.H., Garrafo H.M., Spande T.F., Daly J.W. Alkaloids of anuran skin: antimicrobial function?. Z. Naturforsch. C: J. Biosci. 2005, 60(11-12):932-937.
39. Mebs D., Wagner M.G., Pogoda W., Maneyro R., Kwet A., Kauert G. Lack of bufadienolides in the skin secretion of red bellied toads, Melanophryniscus spp. Anura, Bufonidae), from Uruguay. Comp. Biochem. Physiol. Part C Toxicol. Pharmacol. 2007, 144(4):398-402.
40. Meng Y., Whiting P., Sik V., Rees H.H., Dinan L. Ecdiesteroids and bufadienolides from Helleborus torquatus (Ranunculaceae). Phytochemistry 2001, 57(3):401-407.
41. Moodley N., Crouch N.R., Mulholland D.A. Bufadienolides from Drimia macrocentra and Urginea riparia (Hyacinthaceae: Urgineoideae). Phytochemistry 2007, 68(19):2415-2419.
42. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 16:55-63.
43. Nasu K., Nishida M., Ueda T., Takai N., Bing S., Narahara H., Miyakawa I. Bufalin induces apoptosis and the G0/G1 cell cycle arrest of endometriotic stromal cells: a promising agent for the treatment of endometriosis. Mol. Hum. Reprod. 2005, 11(11):817-823.
44. Nogawa T., Kamano Y., Yamashita A., Pettit G.R. Isolation and structure of five new cancer cell growth inhibitory bufadienolides from the Chinese traditional drug Ch'an Su. J. Nat. Prod. 2001, 64(9):1148-1152.
45. Pettit G.R., Dias D.J.R. Bufadienolides. 13. Conversion of 3β-hydroxy-17-oxoandrost-5-ene to 3β-acetoxy-5β,14α-bufa-20,22-dienolide. J. Org. Chem. 1971, 56(21):3207-3211.
46. Pettit G.R., Kamano Y. Bufadienolides. 27. synthesis of Telocinobufagin. J. Org. Chem. 1974, 39(17):2632-2634.
47. Pettit G.R., Kasturi T.R., Knight J.C., Jaeggi K.A. Bufadienolides. 9. Isobufalin. J. Org. Chem. 1970, 35(6):1410-1414.
48. Pohl T., Koorbanaly C., Crouch N.R., Mulholland D.A. Bufadienolides from Drimia robusta and Urginea altissima (Hyacinthaceae). Phytochemistry 2001, 58(4):557-561.
49. Preusser H.J., Habermehl G., Sablofski M., Schmall-Haury D. Antimicrobial activity of alkaloids from amphibian venoms and effects on the ultrastructure of yeast cells. Toxicon 1975, 13(4):285-289.
50. Pukala T.L., Bowie J.H., Maselli V.M., Musgrave I.F., Tyler M.J. Host-defence peptides from the glandular secretions of amphibians: structure and activity. Nat. Prod. Rep. 2006, 23(3):368-393.
51. Riera A.S., Daud A., Gallo A., Genta S., Aybar M., Sánchez S. Antibacterial activity of lactose-binding lectins from Bufo arenarum skin. Biocell 2003, 27(1):37-46.
52. Rollins-Smith L.A. The role of amphibian antimicrobial peptides in protection of amphibians from pathogens linked to global amphibian declines. Biochim. Biophys. Act. Biomembr. 2009, 1788(8):1593-1599.
53. Rollins-Smith L.A., Colon L.M. Antimicrobial peptides defenses against chytridiomycosis, an emerging infectious disease of amphibian populations. Develop. Comp. Immunol. 2005, 29:589-598.
54. Santa Coloma A., Garrafo H.M., Pignataro O.P., Charreau E.H., Gros E.G. Steroids: biosynthesis of bufadienolides in toads. V. The origin of the cholesterol used by toad parotoid glands for biosynthesis of bufadienolides. Steroids 1984, 44(1):11-22.
55. Schneider R., Wray V., Nimtz M., Lehmanni W.D., Kirch U., Antolovic R., Schoner W. Bovine adrenals contain, in addition to ouabain, a second inhibitor of the sodium pump. J. Biol. Chem. 1998, 273(2):784-792.
56. Schoner W., Scheiner-Bobis G. Endogenous cardiac glycosides: hormones using the sodium pump as signal transducer. Semin. Nephrol. 2005, 25(5):343-351.
57. Shimada K., Sato Y., Nambara T. Occurrence of marinobufotoxin and telocinobufotoxin homologs in the skin of Bufo bankorensis BORBOUR. Chem. Pharm. Bull. 1987, 35(6):2300-2304.
58. Shimada K., Ishii N., Nambara T. Studies on steroids. CCXXII. Occurrence of bufadienolides in the skin of Bufo viridis Laur. Chem. Pharm. Bull. 1986, 34(8):3454-3457.
59. +-Adenosine triphosphatase. J. Pharmacobiodyn. 1986, 9:755-759.
60. +-Adenosine triphosphatase. J. Pharmacobiodyn. 1985, 8:1054-1059.
61. Singh N.P., McCoy M.T., Tice R.R., Scheider E.L. A simple technique for quantification of low levels of DNA damage in individual cells. Exp. Cell Res. 1988, 175:184-191.
62. Steyn P.S., Heerden F.V. Bufadienolides of plant and animals origin. Nat. Prod. Rep. 1998, 15(4):397-413.
63. Supratman U., Fugita T., Akiyama K., Hayashi H. New insecticidal bufadienolide, bryophyllin C, from Kalanchoe pinnata. Biosci. Biotechnol. Biochem. 2000, 64(6):1310-1312.
64. Taniguchi M., Kubo I. Ethnobotanical drug discovery based on medicine men's trials in the African savanna: screening of east African plants for antimicrobial activity. J. Nat. Prod. 1993, 56:1539-1546.
65. Tempone A.G., Pimenta D.C., Lebrun I., Sartorelli P., Taniwaki N.N., de Andrade H.F., Antoniazzi M.M., Jared C. Antileishmanial and antitrypanosomal activity of bufadienolides isolated from the toad Rhinella jimi parotoid macrogland secretion. Toxicon 2008, 52(1):13-21.
66. Terness P., Navolan D., Dufter C., Kopp B., Opelz G. The T-cell suppressive effect of bufadienolides: structural requirements for their immunoregulatory activity. Int. Immunopharm. 2001, 1:119-134.
67. Toledo R.R., Jared R. Cutaneous granular glands and amphibian venoms. Comp. Biochem. Physiol. Part A: Mol. Integr. Physiol. 1995, 111(1):1-29.
68. Verpoorte R., Phan Q.K., Svendsen A.B. Chemical constituents of Vietnamese toad venom, collected from Bufo melanostictus Schneider. Part II. The bufadienolides. J. Nat. Prod. 1980, 43(3):347-352.
69. Vu H., Ianosi-irimie M., Danchuk S., Rabon E., Nogawa T., Kamano Y., Pettit G.R., Wiese T., Puschett J.B. Resibufogenin corrects hypertension in a rat model of human preeclampsia. Exp. Biol. Med. 2006, 231(2):215-220.
70. Wu P.-L., Hsu Y.-L., Wu T.-S., Bastow K.F., Lee K.-H. Kalanchosides A-C, new cytotoxic bufadienolides from the aerial parts of kalanchoe gracilis. Org. Lett. 2006, 8(23):5207-5210.
71. Ye M., Han J., An D., Tu G., Guo D. New cytotoxic bufadienolides from the biotransformation of resibufogenin by Mucor polymorphosporus. Tetrahedron 2005, 61(37):8947-8955.
72. Ye M., Han J., Tu G., An D., Guo D. Microbial Hydroxylation of Bufalin by Cunninghamella blakesleana and Mucor spinosus. J. Nat. Prod. 2005, 68(4):626-628.
73. Yin X.H., Li S.N., Zhang L., Zhu G.N., Zhuang H.S. Evaluation of DNA damage in Chinese toad (Bufo bufo gargarizans) after in vivo exposure to sublethal concentrations of four herbicides using the comet assay. Ecotoxicol 2008, 17(4):280-286.
74. Yoshida S., Kamano Y., Sakai T. Studies on the surface anesthetic activity of bufadienolides isolated from Ch'an Su. Chem. Pharm. Bull. 1976, 24(8):1714-1717.
75. Zhang J., Sun Y., Liu J.-H., Yua B.-Y., Xu Q. Microbial transformation of three bufadienolides by Nocardia sp. and some insight for the cytotoxic structure-activity relationship (SAR). Bioorg. Med. Chem. Lett. 2007, 17(22):6062-6065.